HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Riccardo Montioli Selected Research

Primary hyperoxaluria type 1

1/2016Caenorhabditis elegans AGXT-1 is a mitochondrial and temperature-adapted ortholog of peroxisomal human AGT1: New insights into between-species divergence in glyoxylate metabolism.
2/2014The chaperone role of the pyridoxal 5'-phosphate and its implications for rare diseases involving B6-dependent enzymes.
1/2012Molecular insights into primary hyperoxaluria type 1 pathogenesis.
11/2011Human liver peroxisomal alanine:glyoxylate aminotransferase: characterization of the two allelic forms and their pathogenic variants.
3/2009Molecular Insight into the Synergism between the Minor Allele of Human Liver Peroxisomal Alanine:Glyoxylate Aminotransferase and the F152I Mutation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Riccardo Montioli Research Topics

Disease

9Primary Hyperoxaluria (Oxaluria, Primary)
01/2016 - 11/2007
6Gyrate Atrophy
01/2021 - 02/2014
5Primary hyperoxaluria type 1
01/2016 - 03/2009
4Parkinson Disease (Parkinson's Disease)
01/2016 - 12/2011
3Inborn Genetic Diseases (Disease, Hereditary)
09/2021 - 01/2012
3Rare Diseases (Rare Disease)
10/2015 - 02/2014
2Neurodegenerative Diseases (Neurodegenerative Disease)
09/2021 - 01/2012
2Blindness (Hysterical Blindness)
01/2021 - 01/2017
2Aromatic amino acid decarboxylase deficiency
10/2014 - 04/2013
1Neoplasms (Cancer)
11/2017
1Hydroxykynureninuria
02/2014
1Homocystinuria
02/2014
1Hypokinesia (Bradykinesia)
01/2012
1Tremor (Tremors)
01/2012
1Nervous System Diseases (Neurological Disorders)
01/2012
1Schizophrenia (Dementia Praecox)
12/2011
1Periodontitis
11/2006

Drug/Important Bio-Agent (IBA)

13EnzymesIBA
01/2020 - 11/2007
11Alanine-glyoxylate transaminase (alanine-glyoxylate aminotransferase)IBA
01/2016 - 11/2007
10PyridoxalIBA
01/2020 - 11/2006
4OrnithineIBA
01/2021 - 01/2017
4Transaminases (Aminotransferases)IBA
01/2021 - 01/2017
4Dopamine (Intropin)FDA LinkGeneric
01/2020 - 12/2011
4Serotonin (5 Hydroxytryptamine)IBA
01/2020 - 12/2011
3Aromatic-L-Amino-Acid DecarboxylasesIBA
09/2021 - 01/2012
3Ornithine-Oxo-Acid Transaminase (Ornithine Aminotransferase)IBA
01/2021 - 01/2019
3glyoxylic acid (glyoxylate)IBA
01/2016 - 01/2012
3Dopa DecarboxylaseIBA
01/2016 - 12/2011
2Proteins (Proteins, Gene)FDA Link
09/2021 - 10/2015
2OxalatesIBA
01/2016 - 03/2009
2Calcium OxalateIBA
09/2015 - 12/2013
2Pyridoxine (Pyridoxin)FDA LinkGeneric
02/2014 - 04/2013
1angiogeninIBA
09/2021
1Retinaldehyde (Retinal)IBA
01/2021
15-fluoromethylornithineIBA
01/2019
1SaltsIBA
01/2019
1ranpirnase (Pannon)IBA
11/2017
1BenserazideIBA
01/2016
1Carbidopa (Lodosyn)FDA LinkGeneric
01/2016
1Levodopa (L Dopa)FDA LinkGeneric
01/2016
1Aromatic Amino Acid Decarboxylase InhibitorsIBA
01/2016
1AcidsIBA
10/2015
1Coenzymes (Enzyme Cofactors)IBA
02/2014
1Neurotransmitter Agents (Neurotransmitter)IBA
12/2011
1Glycine (Aminoacetic Acid)FDA LinkGeneric
02/2010
1Histidine (L-Histidine)FDA Link
01/2008
1carbon-sulfur lyaseIBA
11/2006
1cystalysinIBA
11/2006
1Virulence Factors (Pathogenicity Factors)IBA
11/2006

Therapy/Procedure

1Therapeutics
10/2014